{"disease":{"id":"antimicrobial","name":"antimicrobial"},"drugs":{"marketed":[{"drug_id":"astodrimer","indication_name":"Antimicrobial substance","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ASTODRIMER","company_name":"","drug_phase":"phase_3","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":"ASTODRIMER works by interfering with the growth and replication of microorganisms."},{"drug_id":"imipenem","indication_name":"Infection caused by Acinetobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Citrobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Enterococcus spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Escherichia coli strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Pseudomonas aeruginosa strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"imipenem","indication_name":"Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"IMIPENEM","company_name":"Merck Sharp & Dohme B.V.","drug_phase":"marketed","molecular_target":"","drug_class":"imipenem","quality_score":70,"revenue":null,"mechanism":"Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death."},{"drug_id":"cilastatin","indication_name":"Infection caused by Acinetobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Citrobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Enterococcus spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Escherichia coli strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Klebsiella spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Pseudomonas aeruginosa strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"cilastatin","indication_name":"Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Primaxin","generic_name":"CILASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dipeptidase 1","drug_class":"Renal Dehydropeptidase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body."},{"drug_id":"relebactam","indication_name":"Infection caused by Acinetobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Citrobacter spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Enterococcus spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Escherichia coli strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Klebsiella spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Pseudomonas aeruginosa strain resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."},{"drug_id":"relebactam","indication_name":"Infection caused by Serratia spp resistant to carbapenem antimicrobial drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Recarbrio","generic_name":"RELEBACTAM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"","drug_class":"Renal Dehydropeptidase Inhibitor [EPC]","quality_score":34,"revenue":null,"mechanism":"Recarbrio works by inhibiting the beta-lactamase enzymes produced by certain bacteria, allowing carbapenem antibiotics to effectively target and kill the bacteria."}],"pipeline":[],"offLabel":[],"totalMarketed":21,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06358872","title":"Azithromycin for Child Survival in Niger II","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":3300000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06388278","title":"Cost-effectiveness Analysis of an Antimicrobial Stewardship Program in Regione Lombardia (RF-net2018)","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT05451836","title":"N-of-1 Trials of Interventions to Improve Decision-making for Antibiotic Use","phase":"NA","overall_status":"COMPLETED","enrollment_count":15157,"lead_sponsor_name":"Tan Tock Seng Hospital","has_results":false},{"nct_id":"NCT05568654","title":"Reducing Antimicrobial Overuse Through Targeted Therapy for Patients With Community-Acquired Pneumonia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":12500,"lead_sponsor_name":"The Cleveland Clinic","has_results":false},{"nct_id":"NCT07431190","title":"British Columbia Prescriber Feedback Program - Antimicrobial Resistance","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":7626,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT05378880","title":"Optimising Community Antibiotic Use and Infection Control With Behavioural Interventions in Burkina Faso and DR Congo","phase":"NA","overall_status":"COMPLETED","enrollment_count":5532,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT07226557","title":"Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT07233837","title":"Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units","phase":"NA","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Hospital Israelita Albert Einstein","has_results":false},{"nct_id":"NCT06356285","title":"Testing New Ways to Name Antimicrobial Resistance","phase":"NA","overall_status":"COMPLETED","enrollment_count":4296,"lead_sponsor_name":"Imperial College London","has_results":true},{"nct_id":"NCT07237971","title":"Cocreating Action to Improve Rationality in the Health System","phase":"NA","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Universidad Miguel Hernandez de Elche","has_results":false},{"nct_id":"NCT03005145","title":"Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness","phase":"NA","overall_status":"COMPLETED","enrollment_count":3622,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT04328090","title":"Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship","phase":"NA","overall_status":"COMPLETED","enrollment_count":2473,"lead_sponsor_name":"China National Center for Cardiovascular Diseases","has_results":false},{"nct_id":"NCT04388293","title":"Using Antibiotics Wisely - An Antimicrobial Stewardship Program","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT04268342","title":"Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1626,"lead_sponsor_name":"The University of Queensland","has_results":false},{"nct_id":"NCT06882070","title":"ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage","phase":"","overall_status":"COMPLETED","enrollment_count":1600,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT07234331","title":"A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.","phase":"","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT05734391","title":"Surveillance of Healthcare-associated Infections & Antimicrobial Resistance","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1500,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT05089760","title":"Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China","phase":"","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT05285657","title":"Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases.","phase":"NA","overall_status":"COMPLETED","enrollment_count":1176,"lead_sponsor_name":"Institut de Recherche en Sciences de la Sante, Burkina Faso","has_results":false},{"nct_id":"NCT07352371","title":"Metaphors to Enhance Antibiotic Appropriate Use Knowledge and Behaviours to Reduce Educational Disparities","phase":"NA","overall_status":"COMPLETED","enrollment_count":866,"lead_sponsor_name":"Bo Yan","has_results":false},{"nct_id":"NCT05942157","title":"Therapeutic Drug Monitoring in Patients With Difficult-to-Treat Gram-Negative Bacterial Infections","phase":"NA","overall_status":"UNKNOWN","enrollment_count":810,"lead_sponsor_name":"Singapore General Hospital","has_results":false},{"nct_id":"NCT05960084","title":"Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia","phase":"","overall_status":"UNKNOWN","enrollment_count":803,"lead_sponsor_name":"Erasmus Medical Center","has_results":false},{"nct_id":"NCT06566898","title":"Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Shanghai General Hospital, China","has_results":false},{"nct_id":"NCT03633643","title":"Cotrimoxazole Prophylaxis in Transurethral Resection or Greenlight Laser Vaporisation of the Prostate","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":728,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03388944","title":"PCT Guided Stopping of Antibiotic Therapy in Children With Sepsis","phase":"NA","overall_status":"COMPLETED","enrollment_count":561,"lead_sponsor_name":"All India Institute of Medical Sciences","has_results":false},{"nct_id":"NCT04182230","title":"UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Cwm Taf University Health Board (NHS)","has_results":false},{"nct_id":"NCT05370846","title":"The Impact of the Establishment of a New AMS CPS in a Rural Hospital in Austria","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"University of Ulster","has_results":false},{"nct_id":"NCT05445414","title":"A Mobile App Serious Game to Increase Awareness of Antibiotic Use in the Community","phase":"NA","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"Tan Tock Seng Hospital","has_results":false},{"nct_id":"NCT04544072","title":"Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Universitair Ziekenhuis Brussel","has_results":false},{"nct_id":"NCT03571230","title":"Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT07094984","title":"Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT07393308","title":"Development and Implementation of Mobile Antibiograms to Optimize Empirical Antibiotic Prescriptions Among Prescribers in Tertiary Hospitals in Tanzania","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Muhimbili University of Health and Allied Sciences","has_results":false},{"nct_id":"NCT03440918","title":"Impact of a Procalcitonin Testing and Treatment Algorithm on Antibiotic Use and Outcomes in the Pediatric Intensive Care Unit","phase":"NA","overall_status":"COMPLETED","enrollment_count":271,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true},{"nct_id":"NCT07246837","title":"Diagnostic Stewardship Intervention to Reduce Inappropriate Antibiotic Use for Urinary Tract Infections in Primary Care","phase":"NA","overall_status":"RECRUITING","enrollment_count":252,"lead_sponsor_name":"Baylor College of Medicine","has_results":false},{"nct_id":"NCT07177690","title":"A Study of the Impact of Penicillin Allergy on Antimicrobial Resistance and ouTcomes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":214,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT07035535","title":"The Predictive Value of Molecular Diagnostic Techniques in the Antimicrobial- Resistance Phenotypes of Pathogens","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06156956","title":"Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Human Biome Institute S.A.","has_results":false},{"nct_id":"NCT05378217","title":"AMR-DetecTool for the Diagnostic of MDR Bacterial Infections","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03583749","title":"Pharmacokinetics and Safety of Antimicrobial Agents Administered by Subcutaneous Route in Patients AGEd Over 65 Years","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03711292","title":"Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings","phase":"NA","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","has_results":false},{"nct_id":"NCT06946667","title":"Resistance Characteristics and Development of Diagnostic Model for Postoperative UTI in Patients With Kidney Stones","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Xingxin Jiang","has_results":false},{"nct_id":"NCT03794479","title":"Intestinal Microbiota and Antimicrobial Resistance in Hong Kong Residents After Travel","phase":"","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06953804","title":"Optimal Implementation of Antimicrobial Stewardship in General Practice","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Wollongong","has_results":false},{"nct_id":"NCT06651047","title":"PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Bologna","has_results":false},{"nct_id":"NCT03139253","title":"Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Yanqing Li","has_results":false},{"nct_id":"NCT05380869","title":"POCT PCT in Outpatient LRTI","phase":"NA","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Hannover Medical School","has_results":false},{"nct_id":"NCT07054021","title":"Retrospective Frenectomy Analysis: Techniques and Adjunctive Antimicrobials","phase":"","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Saglik Bilimleri Universitesi","has_results":false},{"nct_id":"NCT06666998","title":"Real-World Pharmacokinetic/Pharmacodynamic Study of Eravacycline in Critically III Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Sichuan Provincial People's Hospital","has_results":false},{"nct_id":"NCT06605677","title":"Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors.","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Abu Dhabi Health Services Company","has_results":false},{"nct_id":"NCT05751317","title":"Phenotypic and Genotypic Variations of Enterococcus Spp","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Sohag University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}